期刊文献+

机械通气治疗新生儿肺透明膜病的临床分析 被引量:2

Clinical analysis of mechanical ventilation treatment for pulmonary hyaline membrane disease in newborn
下载PDF
导出
摘要 目的探讨新生儿肺透明膜病(HMD)的呼吸机治疗,分析相关干预措施和围生期因素对疾病转归的影响。方法回顾性分析我院新生儿重症监护病房(NICU)2002年7月~2004年9月收治的35例经机械通气治疗的HMD患儿临床资料,对HMD治愈组和未愈组的呼吸机参数、肺表面活性物质(PS)和静脉营养的应用、胎龄、出生体重、新生儿Apgar评分、宫内缺氧等进行比较。结果呼吸机治疗HMD的治愈率为71.4%,呼吸机相关性肺炎的发生率为34.3%。HMD治愈组和未愈组的呼吸机初调参数及最高参数中的吸入氧浓度(FiO2)、呼吸频率(RR)、呼气末正压(PEP)和吸气时间(Ti)等,以及胎龄、5分钟Apgar评分比较两组间均无显著性差异(P>0.05);出生体重、1分钟Apgar评分、宫内缺氧、最高参数中的吸气峰压(PIP)、静脉营养天数及应用PS等方面两组间存在显著性差异(均P<0.05)。结论围生期一些高危因素影响HMD的转归,机械通气是治疗HMD的重要手段,同时辅以PS和静脉营养应用可提高HMD的治愈率。 Objective To explore the effect of assisted mechanical ventilation on hyaline membrane disease (HMD) of newborn, and to analyze the remedies and perinatal risk factors of affecting the prognosis of HMD. Methods Thirty-five newborns with HMD were treated by respirator in NICU between July, 2002 to September, 2004. The differences of operator parameters, use of pulmonary surfactant and parenteral nutrition, birth weight, Apgar score, and fetal hypoxia between the .cured group and uncured group were compared. Results The percentage of curing of HMD by respirator was 71.4%, and the most sommon complication was the ventilator associated pneumonia (34.3 % ). There was no significant difference between the cured group and uncured group in initial parm^- ters of ventilator, and F1O2, respiratoryl rate(RR), positive end-expirator pressure (PEEP) time of inspiration(Ti) among the highest parameters, gestationl age, Apgar score at 5 min (all P 〉 0.05). But the significant differences between the two groups were observed ih birth weight, Apgar score at 1 min, fetal hypoxia, peak inspiratory pressure (PIP) of the highest parameters, the use of surfactant and parenteral nutrition (all P 〈 0.05). Conclusion ~ Some of perinatal high risk factors contribute to prognosis of HMD. Assisted mechanical ventilation, an important procedure in the treatment of HMD, combined with the use of surfactant and parenteral nutrition can improve its survival rate.
出处 《现代医学》 2005年第3期163-166,共4页 Modern Medical Journal
关键词 新生儿 机械通气 肺表面活性物质 静脉营养 肺透明膜病 围生期 危险因素 预后 newbom mechanical ventilation pulmonary surfactant parenteral nutrition hyaline membrane disease perinatal stage perinatal risk factor prognosis
  • 相关文献

参考文献5

  • 1陆长东,何爱兰,杨黎焱,姚霖,何莉,汤慧丽.肺表面活性物质对新生儿肺透明膜病呼吸力学的影响[J].中华急诊医学杂志,2004,13(6):370-372. 被引量:18
  • 2周小光 肖昕 农绍汉.新生儿机械通气治疗学[M].北京:人民卫生出版社,2004.82.
  • 3MOREHEAD R S,PINTO S J. Ventilator-associated pneumonia[J]. Arch Intern Med,2000,160:1926-1936.
  • 4EWIG S, BAUER T, TORRES A.The pulmonary physician in critical care nosocomial pneumonia[J]. Thorax,2002,57:366-371.
  • 5FIGUERAS-ALOY J,QUERO J, CARBONELL-ESTRANY X,et al. Early administration of the second dose of surfactant(beractant) in the treatment of severe hyaline membrane disease[J]. Acta Paediatr,2001,90:296-301.

二级参考文献6

  • 1Rodriguez RJ, Martin RJ. Exogenous surfactant therapy in newborns.Respir Care Clin N Am, 1999, 5: 595-616.
  • 2Sinn JK, Ward MC, Henderson - Smart DJ. Developmental outcome of preterm infants after surfactant therapy: systematic review of randomized controlled trials. J Paediatr Child Health, 2002, 38:597-600.
  • 3Kelly E, Bryan H, Possmayer F. et al. Compliance of the respiratory system in newborn infants pre - and post surfactant replacement therapy.PadiatrPumonol, 1993, 15: 225-230.
  • 4Baraldi E, pettenazzo A, Filippone M. et al. Rapid improvement of static compliance after surfactant treatment in preterm infants with respiratory distress syndrome. Pediatr Pulmonol, 1993, 15: 157- 162.
  • 5Enhorning G , Duffy LC, Welliver R . Pulmonary surfactant maintains patency of conducting airways in the rat. Am J Respir Crit Care Med,1995, 151: 554- 556.
  • 6陆铸今,张灵恩.呼吸力学监测在儿科监护室中的应用[J].中国实用儿科杂志,2001,16(7):389-391. 被引量:1

共引文献19

同被引文献10

  • 1董红霞,倪敏霞,邵媛仙.早产儿呼吸窘迫综合征机械通气下加用肺泡表面活性物质疗效观察[J].中国基层医药,2005,12(4):462-462. 被引量:8
  • 2刘志伟,沈月华,陈庆生.产前地塞米松预防早产儿呼吸窘迫综合征[J].临床儿科杂志,2005,23(2):117-118. 被引量:8
  • 3胡亚美 江载芳.诸福棠实用儿科学[M](第7版)[M].北京:人民卫生出版社,2002.1199-1201.
  • 4Lanteri CJ,Willet KE,Kano S,et al.Time course of changes in lung mechanics following etal steroid treatment[J].Am J Respir Crit Care Med,1994,150(3):759-765.
  • 5Crowley P,Chalmers I,Keirse MJ.The effects of corticosteroid administration before preterm delivery:An overview of the evidence from controlled trials[J].Br J Obstet Gynaecol,1990,97(1):11-25.
  • 6胡亚美,江载芳,诸福棠.实用儿科学[M].7版.北京人民生出版社.2002:1167-1175.
  • 7谢辛,苟文丽.《妇产科学》[M].8版.人民卫生出版社,2013,3:148.
  • 8Lanteri C J, Willet KE, Kano S, et al. Time course of changes in lung mechanics following etal steroid treatment[ J]. Am J Respir Crit Care Med, 1994,150:759 - 765.
  • 9Crowley P, Chalmers I,Keirse MJ. The effects of eorticosteroid ad- ministration before pretermde livery: An over view of the evidence from controlled trials [ J ]. Br J Obstet Gynaecol, 1990,97 : 11 - 25.
  • 10李惠琴.早产孕妇产前应用地塞米松对早产儿影响的临床分析[J].中国优生与遗传杂志,2009,17(7):69-70. 被引量:2

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部